RS
BIO icon

Rakuten Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Rakuten Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed -$8.48K – 895
2025
Q4 		$8.48K Buy
28
+25
+833% +$7.8K ﹤0.01% 451
2025
Q3 		$841 Sell
3
-63
-95% -$17.1K ﹤0.01% 728
2025
Q2 		$15.9K Buy
66
+33
+100% +$7.8K 0.01% 348
2025
Q1 		$8.04K Buy
33
+20
+154% +$6.02K ﹤0.01% 433
2024
Q4 		$4.27K Sell
13
-9
-41% -$3.06K ﹤0.01% 500
2024
Q3 		$7.36K Buy
22
+8
+57% +$2.54K ﹤0.01% 378
2024
Q2 		$3.82K Sell
14
-56
-80% -$16.3K ﹤0.01% 419
2024
Q1 		$24.2K Buy
70
+23
+49% +$7.56K 0.01% 246
2023
Q4 		$15.2K Buy
+47
New +$14.7K 0.01% 256

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rakuten Securities's BIO Position: Q1 2026 in Review

Rakuten Securities sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 28 shares — an estimated $8.48K sold.

Rakuten Securities first reported a position in BIO in Q4 2023 and held it in 9 quarters. The position peaked at $24.2K in Q1 2024. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Rakuten Securities reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Rakuten Securities sold 28 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $8.48K.
  • Rakuten Securities first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and held it in 9 quarters.
  • Rakuten Securities's Bio-Rad Laboratories Class A position peaked at $24.2K in Q1 2024.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Rakuten Securities's 13F filing for Q1 2026, filed 1 May 2026.